drugset / Trial / NCT00835796

Finasteride 5 mg Tablets, Non-fasting

NCT00835796

Phase 1 Completed 20 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study is to compare the relative bioavailability of finasteride 5 mg tablets (manufactured and distributed by TEVA Pharmaceuticals USA) with that of PROSCAR® 5 mg tablets (Merck) in healthy, adult, non-smoking, male subjects under non-fasting conditions.

Timeline

Start
2002-06
Primary completion
2002-07
Completion
2002-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Finasteride Small molecule 5 mg

Indications

No indication recorded.